These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36395067)
1. How I diagnose and treat acute graft-versus-host disease after solid organ transplantation. Cooper JP; Abkowitz JL Blood; 2023 Mar; 141(10):1136-1146. PubMed ID: 36395067 [TBL] [Abstract][Full Text] [Related]
2. T-cell chimerism prior to graft-versus-host disease. Noguchi M; Shindo T; Yamada Y; Date H Eur J Cardiothorac Surg; 2021 Jul; 60(1):194-196. PubMed ID: 33495782 [TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease. Houston BL; Yan M; Tinckam K; Kamel-Reid S; Chang H; Kuo KH; Tsien C; Seftel MD; Avitzur Y; Grant D; Cserti-Gazdewich CM Transfusion; 2016 Apr; 56(4):962-9. PubMed ID: 26892365 [TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of recipients of both bone marrow and solid organ transplants. A review. Dey B; Sykes M; Spitzer TR Medicine (Baltimore); 1998 Sep; 77(5):355-69. PubMed ID: 9772924 [TBL] [Abstract][Full Text] [Related]
6. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review. Mawad R; Hsieh A; Damon L Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417 [TBL] [Abstract][Full Text] [Related]
7. The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation. Jacobs MT; Olson M; Ferreira BP; Jin R; Hachem R; Byers D; Witt C; Ghobadi A; DiPersio JF; Pusic I Am J Transplant; 2020 Feb; 20(2):589-592. PubMed ID: 31446673 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation. Schwinghammer TL; Bloom EJ Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255 [TBL] [Abstract][Full Text] [Related]
9. Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruption. Russell AJ; Musiek AC; Staser KW; Rosman IS J Cutan Pathol; 2021 Dec; 48(12):1480-1488. PubMed ID: 34173980 [TBL] [Abstract][Full Text] [Related]
10. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
11. Solid-Organ Graft-Versus-Host Disease After Liver Transplant: A Case Report. Auerbach JS; Schott CK Crit Care Nurse; 2016 Jun; 36(3):e7-e11. PubMed ID: 27252108 [TBL] [Abstract][Full Text] [Related]
12. Acute graft-versus-host disease of the heart. Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193 [TBL] [Abstract][Full Text] [Related]
13. Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea. Kang WH; Hwang S; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Ha TY; Kim WJ; Kim SH; Cho HD; Kwon JH; Jwa EK; Lee SG Transplant Proc; 2016 Dec; 48(10):3368-3372. PubMed ID: 27931583 [TBL] [Abstract][Full Text] [Related]
14. Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: Case report and review of the literature. Stanley K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Jones K; Cieply K; Sindhi R Pediatr Transplant; 2019 Mar; 23(2):e13350. PubMed ID: 30672115 [TBL] [Abstract][Full Text] [Related]
15. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Weisdorf D; Haake R; Blazar B; Miller W; McGlave P; Ramsay N; Kersey J; Filipovich A Blood; 1990 Feb; 75(4):1024-30. PubMed ID: 2302454 [TBL] [Abstract][Full Text] [Related]
16. Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature. Sharma A; Armstrong AE; Posner MP; Kimball PM; Cotterell AH; King AL; Fisher RA; Godder K Ann Transplant; 2012 Dec; 17(4):133-9. PubMed ID: 23274334 [TBL] [Abstract][Full Text] [Related]
17. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model. Li ZY; Wang CQ; Lu G; Pan XY; Xu KL Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072 [TBL] [Abstract][Full Text] [Related]
18. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD. Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018 [TBL] [Abstract][Full Text] [Related]